Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Priovant Therapeutics, Inc.
NCT07218770 · Active Noninfectious Uveitis Affecting the Posterior Segment
NCT06974162 · Uveitis, Aqueous Humor, and more
NCT07145008 · Macular Edema (ME), Non Infectious Uveitis
NCT05486468 · Uveitis, Uveitis, Posterior, and more
NCT05200715 · Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, and more
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Phoenix, Arizona
Clinical Trial Site
Bakersfield, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions